AU2003243058A8 - Methods for using the cd163 pathway for modulating an immune response - Google Patents
Methods for using the cd163 pathway for modulating an immune responseInfo
- Publication number
- AU2003243058A8 AU2003243058A8 AU2003243058A AU2003243058A AU2003243058A8 AU 2003243058 A8 AU2003243058 A8 AU 2003243058A8 AU 2003243058 A AU2003243058 A AU 2003243058A AU 2003243058 A AU2003243058 A AU 2003243058A AU 2003243058 A8 AU2003243058 A8 AU 2003243058A8
- Authority
- AU
- Australia
- Prior art keywords
- pathway
- modulating
- methods
- immune response
- immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38368902P | 2002-05-27 | 2002-05-27 | |
EP02077071A EP1367393A1 (en) | 2002-05-27 | 2002-05-27 | Methods for using the CD 163 pathway for modulating an immune response |
US60/383,689 | 2002-05-27 | ||
EP02077071.5 | 2002-05-27 | ||
PCT/NL2003/000395 WO2003100419A1 (en) | 2002-05-27 | 2003-05-27 | Methods for using the cd163 pathway for modulating an immune response |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003243058A1 AU2003243058A1 (en) | 2003-12-12 |
AU2003243058A8 true AU2003243058A8 (en) | 2003-12-12 |
Family
ID=29585706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003243058A Abandoned AU2003243058A1 (en) | 2002-05-27 | 2003-05-27 | Methods for using the cd163 pathway for modulating an immune response |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003243058A1 (en) |
WO (1) | WO2003100419A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10303974A1 (en) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid β (1-42) oligomers, process for their preparation and their use |
EP1660133B1 (en) * | 2003-05-15 | 2018-04-18 | Therapure Biopharma Inc. | Targeted delivery of anti-viral compounds through hemoglobin bioconjugation |
JP5273642B2 (en) * | 2004-04-23 | 2013-08-28 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Cellular tolerance factor to virus and use of the factor |
KR101667623B1 (en) | 2005-11-30 | 2016-10-19 | 애브비 인코포레이티드 | Monoclonal antibodies against amyloid beta protein and uses thereof |
ES2527661T3 (en) | 2005-11-30 | 2015-01-28 | Abbvie Inc. | Scanning method, process for purifying non-spreadable Abeta oligomers, selective antibodies against said spreadable Abeta oligomers and a process for making said antibodies |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
EP2124952A2 (en) | 2007-02-27 | 2009-12-02 | Abbott GmbH & Co. KG | Method for the treatment of amyloidoses |
GB0917054D0 (en) * | 2009-09-29 | 2009-11-11 | Cytoguide As | Agents, uses and methods |
GB0917044D0 (en) * | 2009-09-29 | 2009-11-18 | Cytoguide As | Agents, uses and methods |
CN102933601B (en) | 2010-04-15 | 2016-06-08 | Abbvie公司 | Amyloid beta binding proteins |
CN103298833B (en) | 2010-08-14 | 2015-12-16 | Abbvie公司 | Amyloid beta associated proteins |
US11986536B2 (en) | 2019-03-23 | 2024-05-21 | Ablevia Biotech Gmbh | Compound for the sequestration of undesirable antibodies in a patient |
US11634501B2 (en) * | 2019-07-19 | 2023-04-25 | Oncoresponse, Inc. | Immunomodulatory antibodies and methods of use thereof |
AU2020344554A1 (en) * | 2019-09-09 | 2022-03-31 | The Children's Hospital Of Philadelphia | Compositions and methods for treatment of disorders associated with CLEC16A dysfunction or loss |
WO2022063879A1 (en) * | 2020-09-23 | 2022-03-31 | Ablevia Biotech Gmbh | Compound for the sequestration of undesirable antibodies in a patient |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002210383A1 (en) * | 2000-10-16 | 2002-04-29 | Proteopharma Aps | The function of a haptoglobin-haemoglobin receptor and the uses thereof |
-
2003
- 2003-05-27 WO PCT/NL2003/000395 patent/WO2003100419A1/en not_active Application Discontinuation
- 2003-05-27 AU AU2003243058A patent/AU2003243058A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003243058A1 (en) | 2003-12-12 |
WO2003100419A1 (en) | 2003-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2384570B (en) | Modulators | |
ZA200409641B (en) | Novel substituted indoles. | |
EP1494693A4 (en) | Cripto-specific antibodies | |
EP1465179A4 (en) | Disc apparatus | |
EP1535749A4 (en) | Bookmaking apparatus | |
AU2003243058A8 (en) | Methods for using the cd163 pathway for modulating an immune response | |
EP1587483A4 (en) | Methods for modulating an inflammatory response | |
GB2422544B (en) | Immune modulator | |
GB0220809D0 (en) | Immune modulator | |
GB0208928D0 (en) | Methods | |
AU2003282335A1 (en) | Firearm simulation device | |
GB0220045D0 (en) | Methods | |
GB0221711D0 (en) | Methods | |
GB0226878D0 (en) | Antibodies | |
AU2003264722A8 (en) | Methods | |
AU155673S (en) | Wheel for an outdoor cooking device | |
GB0222276D0 (en) | Methods | |
GB0225663D0 (en) | Methods and means for modulating the immune response | |
GB0200526D0 (en) | Methods | |
GB0213580D0 (en) | Methods | |
GB0213579D0 (en) | Methods | |
GB2388238B (en) | An interactive system | |
GB0217243D0 (en) | Fab-u-met holdback | |
GB0220808D0 (en) | Immune modulator | |
ZA200209082B (en) | Barbeque apparatus. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 18, NO 5, PAGE(S) 1100 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME BIOCEROS B.V. I.O., APPLICATION NO. 2003243058, UNDER INID (71) CORRECT THE NAME TO READ BIOCEROS B.V.; MACROZYME B.V. |